BioCentury | Apr 18, 2020
Politics, Policy & Law

Collaborating to clobber COVID-19

...Myers Squibb Eisai Co. Ltd. Eli Lilly and Co. Evotec AG Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Takeda Pharmaceutical Co. Ltd. Versant Partners...
BioCentury | Jun 29, 2018
Financial News

NASH play Akero emerges from stealth with $65M

...Royston. Akero Therapeutics Inc., Cambridge, Mass. Jennie Walters GS-0976, ndi-010976 Amgen Inc. Atlas Venture Bird Rock Bio Jecure Therapeutics Inc. Nimbus Therapeutics LLC Versant Partners...
BioCentury | Feb 2, 2017
Financial News

Versant leads Tarveda’s $30M D round

Tarveda Therapeutics Inc. (Watertown, Mass.) said it raised $30 million in a series D round led by new investor Versant Ventures . Existing investors New Enterprise Associates , Novo A/S , NanoDimension and Flagship Pioneering also participated. Tarveda...
BioCentury | Nov 14, 2011
Finance

Quanticel quantified

Versant Ventures has spurned the traditional syndicate route for cancer play Quanticel Pharmaceuticals Inc. In two years, the VC has formed the company and taken it to a partnership and potential exit. Celgene Corp. (NASDAQ:CELG)...
BioCentury | Jun 20, 2011
Financial News

Tekmira completes private placement of units

...US$5.2 million) Units: 1.8 million Price: C$2.85 (unit) Shares after offering: 12.1 million Placement agent: Versant Partners...
BioCentury | Feb 7, 2011
Financial News

Paladin completes follow-on

...offering: 19.6 million Underwriters: GMP Securities; Bloom Burton; Paradigm Capital; RBC Capital Markets; TD Securities; Versant Partners...
BioCentury | Feb 4, 2011
Financial News

Paladin raises C$35 million

...a follow-on underwritten by GMP Securities; Bloom Burton; Paradigm Capital; RBC Capital Markets; TD Securities; Versant Partners...
BioCentury | Mar 22, 2010
Financial News

Protox completes private placement of units

...million Price: C$0.45 (unit) Shares after offering: 95.7 million Placement agents: Dundee Capital Markets; Canaccord; Versant Partners...
BioCentury | Mar 8, 2010
Financial News

Protox amends private placement of units

...to C$6.5 million ($6.2 million) Price: C$0.45 Units: TBD Placement agents: Dundee Capital Markets; Canaccord; Versant Partners...
BioCentury | Feb 15, 2010
Financial News

Protox proposes private placement of units

...C$8 million (US$7.5 million) Units: TBD Price: C$0.55 (unit) Placement agents: Dundee Capital Markets; Canaccord; Versant Partners...
Items per page:
1 - 10 of 22
BioCentury | Apr 18, 2020
Politics, Policy & Law

Collaborating to clobber COVID-19

...Myers Squibb Eisai Co. Ltd. Eli Lilly and Co. Evotec AG Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Takeda Pharmaceutical Co. Ltd. Versant Partners...
BioCentury | Jun 29, 2018
Financial News

NASH play Akero emerges from stealth with $65M

...Royston. Akero Therapeutics Inc., Cambridge, Mass. Jennie Walters GS-0976, ndi-010976 Amgen Inc. Atlas Venture Bird Rock Bio Jecure Therapeutics Inc. Nimbus Therapeutics LLC Versant Partners...
BioCentury | Feb 2, 2017
Financial News

Versant leads Tarveda’s $30M D round

Tarveda Therapeutics Inc. (Watertown, Mass.) said it raised $30 million in a series D round led by new investor Versant Ventures . Existing investors New Enterprise Associates , Novo A/S , NanoDimension and Flagship Pioneering also participated. Tarveda...
BioCentury | Nov 14, 2011
Finance

Quanticel quantified

Versant Ventures has spurned the traditional syndicate route for cancer play Quanticel Pharmaceuticals Inc. In two years, the VC has formed the company and taken it to a partnership and potential exit. Celgene Corp. (NASDAQ:CELG)...
BioCentury | Jun 20, 2011
Financial News

Tekmira completes private placement of units

...US$5.2 million) Units: 1.8 million Price: C$2.85 (unit) Shares after offering: 12.1 million Placement agent: Versant Partners...
BioCentury | Feb 7, 2011
Financial News

Paladin completes follow-on

...offering: 19.6 million Underwriters: GMP Securities; Bloom Burton; Paradigm Capital; RBC Capital Markets; TD Securities; Versant Partners...
BioCentury | Feb 4, 2011
Financial News

Paladin raises C$35 million

...a follow-on underwritten by GMP Securities; Bloom Burton; Paradigm Capital; RBC Capital Markets; TD Securities; Versant Partners...
BioCentury | Mar 22, 2010
Financial News

Protox completes private placement of units

...million Price: C$0.45 (unit) Shares after offering: 95.7 million Placement agents: Dundee Capital Markets; Canaccord; Versant Partners...
BioCentury | Mar 8, 2010
Financial News

Protox amends private placement of units

...to C$6.5 million ($6.2 million) Price: C$0.45 Units: TBD Placement agents: Dundee Capital Markets; Canaccord; Versant Partners...
BioCentury | Feb 15, 2010
Financial News

Protox proposes private placement of units

...C$8 million (US$7.5 million) Units: TBD Price: C$0.55 (unit) Placement agents: Dundee Capital Markets; Canaccord; Versant Partners...
Items per page:
1 - 10 of 22